Searched for
DFA 02
Dr Reddy's terminates Armis Biopharma's investigation license of DFA-02According to a press release issued by the Indian drug maker, as a result of the termination, Dr Reddy's has regained worldwide rights to D...- Market Now: ICICI Bank, YES Bank most active in terms of valueMost active stocks in terms of value helps investors to identify the stocks with highest trading turnover during the day.
- Top stocks in focus on Friday, 28 July 2017Here is a list of top stocks that are likely to be in focus in today's session.
- Dr Reddy's forms commercialisation pact with CHD BiosciencePhase II studies for DFA-02 have been successfully completed and the product will now be transitioning to Phase III registration studies.
- Dr Reddy's and CHD Bioscience sign up for licensing of a wound care drugThe drug is intended to be used for the prevention of surgical site infections, following non-emergency, elective colorectal surgery.
Load More